Who
Brian M. Posner
Director
Company insider
Files Form 4 as: Director, Firefly Neuroscience; Director, Stran & Company; Chief Financial Officer, electroCore; Chief Financial Officer, Cellectar Biosciences; Chief Financial Officer, Alliqua BioMedical; Chief Financial Officer, Ocean Power Technologies; Chief Financial Officer, Power Medical Interventions; EVP, CFO, Pharmacopeia.
In numbers
- Trades disclosed
- 109
- Buys
- 12
- Sells
- 1
- Bought
- $131K
- Sold
- $5,960
- Companies
- 8
- Companies where not an officer
- 2
- First trade
- 30 Dec 2005
- Last trade
- 25 Sep 2026
- Last filed
- 29 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 25 Sep 2026filed 29 Sep 2026 | AIFF Firefly Neuroscienceoption or derivative · Software | SEC FORM 4 Code A | —84,033 at $0.00 | filing |
| 25 Sep 2026filed 29 Sep 2026 | AIFF Firefly Neuroscienceoption or derivative · Software | SEC FORM 4 Code A | —84,033 at $0.00 | filing |
| 13 Aug 2026filed 14 Aug 2026 | SWAG Stran & CompanyAdvertising & Marketing | SEC FORM 4 Code A | —5,660 at $0.00 | filing |
| 13 Aug 2026filed 14 Aug 2026 | SWAG Stran & CompanyAdvertising & Marketing | SEC FORM 4 Code A | —5,660 at $0.00 | filing |
| 28 Oct 2025filed 30 Oct 2025 | AIFF Firefly Neuroscienceoption or derivative · Software | SEC FORM 4 Code A | —49,262 at $0.00 | filing |
| 10 Mar 2025filed 12 Mar 2025 | AIFF Firefly Neuroscienceoption or derivative · Software | SEC FORM 4 Code A | —16,667 at $0.00 | filing |
| 12 Jan 2024filed 17 Jan 2024 | ECOR electroCoreMedical Devices | SEC FORM 4 Bought | —16,000 at $0.00 | filing |
| 31 Jul 2023filed 2 Aug 2023 | ECOR electroCoreoption or derivative · Medical Devices | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 14 Jan 2022filed 18 Jan 2022 | ECOR electroCoreoption or derivative · Medical Devices | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 10 Dec 2021filed 13 Dec 2021 | ECOR electroCoreMedical Devices | SEC FORM 4 Bought | $7,50010,000 at $0.75 | filing |
| 9 Nov 2021filed 10 Nov 2021 | ECOR electroCoreMedical Devices | SEC FORM 4 Bought | $9,60010,000 at $0.96 | filing |
| 17 Aug 2021filed 19 Aug 2021 | ECOR electroCoreMedical Devices | SEC FORM 4 Sold | $5,9606,478 at $0.92 | filing |
| 18 Jan 2021filed 20 Jan 2021 | ECOR electroCoreoption or derivative · Medical Devices | SEC FORM 4 Code A | —250,000 at $0.00 | filing |
| 12 Jun 2020filed 16 Jun 2020 | ECOR electroCoreoption or derivative · Medical Devices | SEC FORM 4 Code A | —105,000 at $0.00 | filing |
| 27 Jun 2019filed 1 Jul 2019 | ECOR electroCoreoption or derivative · Medical Devices | SEC FORM 4 Code A | —73,033 at $0.00 | filing |
| 6 Jun 2019filed 6 Jun 2019 | ECOR electroCoreMedical Devices | SEC FORM 4 Bought | $17K10,000 at $1.72 | filing |
| 17 Jan 2019filed 18 Jan 2019 | CLRB Cellectar Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 12 Oct 2018filed 15 Oct 2018 | CLRB Cellectar Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —54,000 at $0.00 | filing |
| 6 Apr 2018filed 6 Apr 2018 | CLRB Cellectar Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —80,000 at $0.00 | filing |
| 21 Sep 2017filed 25 Sep 2017 | Alliqua BioMedical | SEC FORM 4 Code F | $30K70,833 at $0.42 | filing |
News
Enovis (NYSE:ENOV) and electroCore (NASDAQ:ECOR) Head to Head SurveyECOR · themarketsdaily.com · 11 Oct 2026Can WAM-V Platform Unlock Growth for Ocean Power Technologies (OPTT)?OPTT · insidermonkey.com · 9 Oct 2026Enovis (NYSE:ENOV) versus electroCore (NASDAQ:ECOR) Financial ContrastECOR · tickerreport.com · 9 Oct 2026Could Palantir Foundry Be a Turning Point for Ocean Power Technologies (OPTT)?OPTT · insidermonkey.com · 9 Oct 2026Ocean Power Technologies wins Naval Postgraduate School order for WAM-V 8 droneOPTT · proactiveinvestors.com · 8 Oct 2026
0 headlines in the last 90 days name Brian M. Posner; 5 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.